Minerva Surgical Inc

XNAS: UTRS

Watchlist

Portfolio

Alert

Share
13.1

Market Cap

Low in industry
-0.4

PE TTM

Negative PE TTM
0

PEG TTM

0.6

Price to Book

Low in industry
8.4

Beta 1Year

Very High Volatility
Board Meeting
The next board meeting for Minerva Surgical Inc is on 16 Jul 2025 for the purpose of Minerva Surgical Inc First Quarter Earnings Conference Call for 2025 See details


Insider Trading disclosures for Minerva Surgical Inc

The latest disclosure was made by Derrick Sung in Minerva Surgical Inc where a trade of 86,956 Common Stock done at an average price of $2.3 was reported to US exchanges on July 19, 2022.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Derrick Sung Director Grant, award, or other acquisition of securities at price $ 2.30 per share. 19 Jul 2022 86,956 86,956 - 2.3 199,999 Common Stock
Jill D. Anderson Director Grant, award, or other acquisition of securities at price $ 2.41 per share. 10 Jun 2022 49,792 49,792 - 2.4 119,999 Common Stock
David M. Renzi Director Grant, award, or other acquisition of securities at price $ 2.41 per share. 10 Jun 2022 49,792 49,792 - 2.4 119,999 Common Stock
Ali Behbahani Director Grant, award, or other acquisition of securities at price $ 2.41 per share. 10 Jun 2022 49,792 58,279 - 2.4 119,999 Common Stock
Niquette Hunt Director Grant, award, or other acquisition of securities at price $ 2.41 per share. 10 Jun 2022 49,792 49,792 - 2.4 119,999 Common Stock
Ross Jaffe Director Grant, award, or other acquisition of securities at price $ 2.41 per share. 10 Jun 2022 49,792 49,792 - 2.4 119,999 Common Stock
Evgueni V. Skalnyi VP Medical Affairs Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2022 49,755 244,725 - 0 Common Stock
Dominique J. Filloux COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2022 60,198 266,289 - 0 Common Stock
Joel R. Jung CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2022 60,198 220,730 - 0 Common Stock
David M. Clapper Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2022 229,732 323,232 - 0 Common Stock
David M. Clapper Director, President and CEO Purchase of securities on an exchange or from another person at price $ 4.94 per share. 13 Dec 2021 25,000 642,660 - 4.9 123,435 Common Stock
Ali Behbahani Director 26 Oct 2021 3,306 8,487 - - Common Stock
Ross Jaffe Director 26 Oct 2021 395,813 0 - - Subordinated Secured Convertible Promissory Note
Ross Jaffe Director 26 Oct 2021 464 0 - - Series D Preferred Stock
Ross Jaffe Director 26 Oct 2021 438 893 - - Series D Preferred Stock
Ross Jaffe Director 26 Oct 2021 432 464 - - Series D Preferred Stock
Ross Jaffe Director 26 Oct 2021 455 1,334 - - Series D Preferred Stock
Ross Jaffe Director 26 Oct 2021 438 896 - - Series D Preferred Stock
Ali Behbahani Director 26 Oct 2021 281 281 - - Common Stock
Ali Behbahani Director 26 Oct 2021 704 985 - - Common Stock
Ali Behbahani Director 26 Oct 2021 4,196 5,181 - - Common Stock
Ali Behbahani Director 26 Oct 2021 3,306 0 - - Series D Preferred Stock
Ali Behbahani Director 26 Oct 2021 281 0 - - Series B Preferred Stock
Ali Behbahani Director 26 Oct 2021 704 0 - - Series C Preferred Stock
Ali Behbahani Director 26 Oct 2021 4,196 0 - - Series D Preferred Stock
Ali Behbahani Director 26 Oct 2021 544 544 - - Series D Preferred Stock
Ali Behbahani Director 26 Oct 2021 523 1,067 - - Series D Preferred Stock
Ali Behbahani Director 26 Oct 2021 516 1,583 - - Series D Preferred Stock
Ali Behbahani Director 26 Oct 2021 501 2,084 - - Series D Preferred Stock
Ali Behbahani Director 26 Oct 2021 480 2,564 - - Series D Preferred Stock
Ali Behbahani Director 26 Oct 2021 742 3,306 - - Series D Preferred Stock
Ross Jaffe Director 26 Oct 2021 775,985 0 - - Subordinated Secured Convertible Promissory Note
Ross Jaffe Director 26 Oct 2021 73,816 0 - - Series D Preferred Stock
Ross Jaffe Director 26 Oct 2021 68,634 73,816 - - Series D Preferred Stock
Ross Jaffe Director 26 Oct 2021 69,613 142,450 - - Series D Preferred Stock
Ross Jaffe Director 26 Oct 2021 72,374 212,063 - - Series D Preferred Stock
Ross Jaffe Director 26 Oct 2021 455 455 - - Series D Preferred Stock
Ross Jaffe Director 26 Oct 2021 73,816 284,437 - - Series D Preferred Stock
Ross Jaffe Director 26 Oct 2021 68,634 210,621 - - Series D Preferred Stock
Ross Jaffe Director 26 Oct 2021 69,613 141,987 - - Series D Preferred Stock
Ross Jaffe Director 26 Oct 2021 72,374 72,374 - - Series D Preferred Stock
Ross Jaffe Director 26 Oct 2021 5,257 0 - - Subordinated Secured Convertible Promissory Note
Ross Jaffe Director 26 Oct 2021 4,888 0 - - Subordinated Secured Convertible Promissory Note
Ross Jaffe Director 26 Oct 2021 4,958 0 - - Subordinated Secured Convertible Promissory Note
Ross Jaffe Director 26 Oct 2021 5,154 0 - - Subordinated Secured Convertible Promissory Note
Ross Jaffe Director 26 Oct 2021 834,568 0 - - Subordinated Secured Convertible Promissory Note
Ross Jaffe Director 26 Oct 2021 94,755 94,755 - - Common Stock
Ross Jaffe Director 26 Oct 2021 284,437 284,437 - - Common Stock
Ross Jaffe Director 26 Oct 2021 1,789 1,789 - - Common Stock
Ross Jaffe Director 26 Oct 2021 818,269 0 - - Subordinated Secured Convertible Promissory Note
Ross Jaffe Director 26 Oct 2021 787,049 0 - - Subordinated Secured Convertible Promissory Note
Ross Jaffe Director 26 Oct 2021 464 1,789 - - Series D Preferred Stock
Ross Jaffe Director 26 Oct 2021 432 1,325 - - Series D Preferred Stock
Ross Jaffe Director 26 Oct 2021 24,760 0 - - Series D Preferred Stock
Ross Jaffe Director 26 Oct 2021 34,986 24,760 - - Series D Preferred Stock
Ross Jaffe Director 26 Oct 2021 35,009 59,746 - - Series D Preferred Stock
Ross Jaffe Director 26 Oct 2021 24,760 94,755 - - Series D Preferred Stock
Ross Jaffe Director 26 Oct 2021 34,986 69,995 - - Series D Preferred Stock
Ross Jaffe Director 26 Oct 2021 35,009 35,009 - - Series D Preferred Stock
Ross Jaffe Director 26 Oct 2021 279,941 0 - - Subordinated Secured Convertible Promissory Note
Ross Jaffe Director 26 Oct 2021 395,556 0 - - Subordinated Secured Convertible Promissory Note
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters